IRIS
ALONCI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.605
EU - Europa 2.058
AS - Asia 362
OC - Oceania 8
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.592
IE - Irlanda 621
SE - Svezia 582
CN - Cina 321
UA - Ucraina 218
IT - Italia 175
DE - Germania 160
FI - Finlandia 109
GB - Regno Unito 94
BE - Belgio 22
PL - Polonia 20
FR - Francia 19
AT - Austria 16
IN - India 14
CA - Canada 12
IR - Iran 9
SG - Singapore 9
NL - Olanda 6
RU - Federazione Russa 6
VN - Vietnam 6
AU - Australia 5
CH - Svizzera 3
NZ - Nuova Zelanda 3
BR - Brasile 2
CZ - Repubblica Ceca 2
NO - Norvegia 2
TR - Turchia 2
CL - Cile 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
LV - Lettonia 1
MX - Messico 1
PT - Portogallo 1
Totale 5.038
Salva come PNG Salva come JPEG
Città #
Dublin 621
Chandler 562
Jacksonville 450
Nyköping 298
Beijing 172
Ashburn 132
Dearborn 122
Princeton 109
Cambridge 106
Medford 106
Messina 97
Ann Arbor 90
Des Moines 90
Boardman 72
Woodbridge 46
New York 45
Wilmington 28
Brussels 22
Lancaster 22
Warsaw 20
Shenyang 18
San Mateo 16
Vienna 16
Hebei 15
Jinan 15
Nanjing 14
Tianjin 13
Bremen 10
Pune 10
Rome 10
Auburn Hills 9
Seattle 9
Hangzhou 8
Houston 8
Ningbo 8
Washington 8
Los Angeles 7
Strasbourg 7
Zhengzhou 7
Ardabil 6
Augusta 6
Dong Ket 6
Lanzhou 6
Falls Church 5
Haikou 5
Helsinki 5
Milan 5
Monmouth Junction 5
Taiyuan 5
Changsha 4
Cosenza 4
Ferrandina 4
Fuzhou 4
Latina 4
Norwalk 4
Ottawa 4
Chapel Hill 3
Esher 3
Guangzhou 3
Jiaxing 3
Kelowna 3
Lausanne 3
Leawood 3
Redwood City 3
Saint Petersburg 3
Civitanova Marche 2
Hefei 2
Indianapolis 2
Kunming 2
Modica 2
Montréal 2
Nienhagen 2
Oslo 2
Padova 2
Palermo 2
Pescara 2
Riva 2
San Gregorio d'Ippona 2
Tappahannock 2
Amsterdam 1
Auckland 1
Baotou 1
Berkeley 1
Boston 1
Brno 1
Cairo 1
Chaoyang 1
Chongqing 1
Christchurch 1
Clearwater 1
Cranbourne East 1
Dongguan 1
Edinburgh 1
Evanston 1
Florence 1
Fremont 1
Gragnano 1
Hanover 1
Hongtong 1
Istanbul 1
Totale 3.576
Salva come PNG Salva come JPEG
Nome #
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 102
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 99
The cancer stem cell hypothesis: a guide to potential molecular targets. 90
L'ipersplenismo: attualità e prospettive future 82
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 76
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 73
E rosette formation in B cell chronic lymphocytic leukemia. 72
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 71
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 70
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 70
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 69
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 68
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 65
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 63
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 62
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 61
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 61
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 60
Serum levels of interleukin-16 in lymphoid malignancies. 60
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 59
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 59
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 59
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 58
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 57
Beta 2 microglobulina ed emopatie maligne 57
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 56
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 56
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 56
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 55
Lipid profile in hematologic neoplasms 53
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 53
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 52
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 51
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 51
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 51
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 51
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 51
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 50
Cardiac involvement in patients with hematologic malignancies. 50
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 50
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 49
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 49
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 48
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 48
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 47
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 47
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 46
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 46
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 46
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 46
MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA 45
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. 45
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 45
Epigenetic therapy in myelodysplastic syndromes. 45
Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. 45
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 45
METHYMAZOLE-INDUCED AGRANULOCYTOSIS AND QUICK RECOVERY WITH G-CSF: CARE REPORT 44
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 44
Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B. 44
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 44
EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN 43
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. 43
Prognostic significance of immunophenotype in chronic lymphocytic leukaemia 42
JAK2-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease. 42
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration 42
Serum levels of interleukin-16 in a multiple myeloma patient with cutaneous involvement. 42
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. 42
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 42
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 41
Standardisation of minimal residual disease in multiple myeloma 41
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 40
Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw 40
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 40
POLYRADICOLONEUROPATHY AS A FORM OF RELAPSE IN A PATIENT WITH ACUTE MEGACARYOCYTIC LEUKAEMIA 39
Serum levels of Interleukin-16 as an important prognostic factor in multiple Myeloma patient with cutaneous involvement 39
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 39
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response 39
Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1. 37
SERUM LEVELS OF CD8-ANTIGEN AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 36
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. 36
E-ROSETTE FORMATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 35
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. 35
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 35
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis 35
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 34
INTRACELLULAR AND SERUM LEVELS OF ALDOLASE ACTIVITY IN B- CHRONIC LYMPHOCYTIC-LEUKEMIA 33
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies. 32
Significance of serum interleukin-16 levels in patients with B-cell chronic lymphocytic leukemia 31
Differential levels of soluble angiopèoietin-2 and Tie-2 in patients with haematological malignancies 31
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. 31
null 31
Screening dei deficit di G-6-PD in un campione di una popolazione scolastica 31
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. 31
Soluble angiogenic factors: Implications for chronic myeloproliferative disorders 29
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. 29
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission. 29
null 28
Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications 28
null 28
Serum levels of angiopoietin-2 and its receptor TIE2 in Chronic myeloproliferative disease 28
Totale 4.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 2 3 8
2019/2020795 102 41 4 36 14 116 122 83 10 122 141 4
2020/2021706 95 3 125 47 29 92 8 41 41 85 81 59
2021/2022641 5 57 14 20 18 8 40 26 13 89 98 253
2022/20231.944 164 168 82 174 165 199 17 110 775 9 58 23
2023/2024401 39 73 28 35 49 118 20 30 3 6 0 0
Totale 5.091